Victrex (OTCMKTS:VTXPF) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Victrex (OTCMKTS:VTXPF) from a sell rating to a hold rating in a report released on Thursday morning, Zacks.com reports.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

Get Victrex alerts:

Separately, ValuEngine upgraded Victrex from a sell rating to a hold rating in a research report on Thursday, August 1st.

Shares of VTXPF opened at $30.40 on Thursday. The stock has a fifty day moving average price of $28.77 and a two-hundred day moving average price of $26.61. Victrex has a 52-week low of $22.41 and a 52-week high of $34.65. The company has a market cap of $2.61 billion, a price-to-earnings ratio of 17.57 and a beta of 2.05.

About Victrex

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.

Featured Article: How to Invest in Growth Stocks

Get a free copy of the Zacks research report on Victrex (VTXPF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.